# Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dacomitinib-compared-with-placebo-in-pretreated-patients-with-advanced-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter M Ellis,Frances A. Shepherd,Michael Millward,Federica Perrone,Lesley Seymour,Geoffrey Liu,Sophie Sun,Byoung Chul Cho,Alessandro Morabito,Natasha B. Leighl,Martin R. Stockler,Christopher W. Lee,Rafal Wierzbicki,Victor Cohen,Normand Blais,Randeep Sangha,Adolfo Favaretto,Jin Hyoung Kang,Ming‐Sound Tsao,Carolyn F. Wilson,Zelanna Goldberg,Keyue Ding,Glenwood Goss,Penelope Ann Bradbury |
| Citations | 130 |
| DOI | 10.1016/s1470-2045(14)70472-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2149654081 |
| PMID | 25439692 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Victor Cohen](https://scholariq.org/researchers/victor-cohen/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.